Ozer Baysal - Agenus Chief Business Officer
AJ81 Stock | EUR 7.80 0.00 0.00% |
Executive
Mr. Ozer Baysal is Chief Commercial Officer, Head of HR of Agenus Inc. Mr. Baysal was Chief Business Officer since January 2013 until July 1, 2017. Prior to joining Agenus Mr. Baysal spent more than 30 years with Pfizer in a broad number of functional and geographic areas, most recently serving as President of Europe, Emerging Markets Region. While at Pfizer, he held key leadership positions in Marketing, Sales, and Manufacturing, and was actively involved with numerous licensing and MA activities since 2017.
Age | 60 |
Tenure | 7 years |
Phone | 781 674 4400 |
Web | https://www.agenusbio.com |
Agenus Management Efficiency
The company has return on total asset (ROA) of (0.2577) % which means that it has lost $0.2577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (18.903) %, meaning that it generated substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
Return On Equity | -18.9 | |||
Return On Asset | -0.26 |
Agenus Inc Leadership Team
Elected by the shareholders, the Agenus' board of directors comprises two types of representatives: Agenus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agenus. The board's role is to monitor Agenus' management team and ensure that shareholders' interests are well served. Agenus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agenus' outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Stein, Chief Scientific Officer | ||
James Gorman, Vice President - Strategic Planning and Portfolio Management | ||
Ozer Baysal, Chief Business Officer | ||
Regina Grebla, VP Communications | ||
Shalini Sharp, Director | ||
John Castle, Head Bioinformatics | ||
Wadih Jordan, Independent Director | ||
Christine Klaskin, Principal Financial Officer, Principal Accounting Officer, Vice President - Finance | ||
Jennifer Buell, Pres Therapeutics | ||
Don Vidic, Vice President Head of Commercial | ||
Brian Corvese, Independent Director | ||
Karen Valentine, Vice President Chief Compliance Officer, General Counsel, Secretary | ||
Evan Ballantyne, CFO | ||
Timothy Wright, Lead Independent Director | ||
Christian Cortis, Chief Strategy Officer and Head of Finance | ||
Julie DeSander, Chief Officer | ||
Ulf Wiinberg, Director | ||
Alexander Duncan, CTO and Head - Research | ||
Tracy Clemente, Chief Officer | ||
Allison JeynesEllis, Director | ||
Garo Armen, Chairman of the Board, CEO | ||
JeanMarie Cuillerot, Chief Medical Officer | ||
Andrea Rabney, IR Contact Officer | ||
Craig Winter, Chief Officer | ||
Robin JD, Chief Officer | ||
Shahzad Malik, Independent Director | ||
Evan Kearns, Vice President General Counsel, Secretary |
Agenus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agenus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -18.9 | |||
Return On Asset | -0.26 | |||
Profit Margin | (2.39) % | |||
Operating Margin | (1.99) % | |||
Current Valuation | 646 M | |||
Shares Outstanding | 304.81 M | |||
Shares Owned By Insiders | 8.96 % | |||
Shares Owned By Institutions | 65.26 % | |||
Price To Earning | (3.13) X | |||
Price To Book | 181.30 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Agenus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Agenus' short interest history, or implied volatility extrapolated from Agenus options trading.
Pair Trading with Agenus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.Moving against Agenus Stock
0.71 | 0QF | Moderna | PairCorr |
0.49 | DBPE | Xtrackers LevDAX | PairCorr |
The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.
The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Agenus Stock analysis
When running Agenus' price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |